PIN THERAPEUTICS

pin-therapeutics-logo

Pin Therapeutics is founded in Feb 2017, fast growing stage with member composition of 25% in USA and 75% in Korea. Drug discovery leaderships are from global pharma and biotech companies along with talented scientists both in Korea and USA. * Active Focus - PinE3: E3 ligase screening cascade for identifying novel warheads - PinGLUE: Assay cascade for molecular glue degrader screening * Programs - Selective Molecular Glue Degrader (CK1ฮฑ) - Molecular Glue Degrader Programs (5-6 Undisclosed) - PROTAC Program (1 Undisclosed)

#SimilarOrganizations #People #Financial #Website #More

PIN THERAPEUTICS

Social Links:

Industry:
Biotechnology

Founded:
2017-02-01

Address:
Seongnam, Kyonggi-do, South Korea

Country:
South Korea

Website Url:
http://www.pintherapeutics.com

Total Employee:
51+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
34.43 M USD

Technology used in webpage:
Nginx CrUX Dataset CrUX Top 10m Slack


Similar Organizations

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

akashi-therapeutics-logo

Akashi Therapeutics

Akashi Therapeutics is a clinical stage biopharmaceutical company.

jenrin-discovery-logo

Jenrin Discovery

Jenrin Discovery is a biopharmaceutical Company.

Current Employees Featured

not_available_image

Hyunsun Jo
Hyunsun Jo CEO @ Pin Therapeutics
CEO

Founder


not_available_image

Hyunsun Jo

Investors List

daewoong-pharmaceutical_image

Daewoong Pharmaceutical

Daewoong Pharmaceutical investment in Series B - Pin Therapeutics

korea-investment-partners_image

Korea Investment Partners

Korea Investment Partners investment in Series B - Pin Therapeutics

korea-investment-securities-d0c5_image

KOREA INVESTMENT & SECURITIES

KOREA INVESTMENT & SECURITIES investment in Series B - Pin Therapeutics

korean-development-bank_image

Korea Development Bank

Korea Development Bank investment in Series B - Pin Therapeutics

dsc-investment_image

DSC Investment

DSC Investment investment in Series B - Pin Therapeutics

kbinvest_image

KB Investment

KB Investment investment in Series B - Pin Therapeutics

company-k_image

Company K Partners

Company K Partners investment in Venture Round - Pin Therapeutics

Official Site Inspections

http://www.pintherapeutics.com Semrush global rank: 4.17 M Semrush visits lastest month: 2.57 K

  • Host name: 203.245.24.54
  • IP address: 203.245.24.54
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "Pin Therapeutics"

Pin Therapeutics

Korea : # 401, L'FORT Halla Vivaldi, 46, Wiryeseoil-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do [email protected]. 070-8693-3497See details»

Pin Therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected] Pin Therapeutics is founded in Feb 2017, fast growing stage with member composition of 25% in USA and 75% in Korea. Drug discovery leaderships โ€ฆSee details»

Pin Therapeutics 2025 Company Profile: Valuation, Funding

Pin Therapeutics General Information Description. Developer of therapeutic drugs designed to be used for chemical biology-driven protein degradation. The company's drugs utilize the body's โ€ฆSee details»

Pin Therapeutics Company Profile | Management and Employees โ€ฆ

[email protected]: Pin Therapeutics Top Competitors. Company Employees Revenue Top technologies; Neu-Age Therapeutics LLC. 7: $2.1 M: Cogentis Therapeutics Inc. โ€ฆSee details»

Pin Therapeutics, Inc. | LinkedIn

Pin Therapeutics, Inc. | 925 followers on LinkedIn. "Creating therapeutic products degrading disease-causing proteins" | "Creating Therapeutic Products Degrading Disease-causing Proteins"See details»

Pin Therapeutics - 2025 Company Profile & Funding - Tracxn

Mar 22, 2025 Pin Therapeutics - Developer of small molecule based therapeutics for the treatment of several diseases. Raised funding from 5 investors. Founded by Hyunsun Jo in the โ€ฆSee details»

Pin Therapeutics - VentureRadar

"Pin Therapeutics, Inc. is a biotech company developing protein degradation therapeutics applicable to various diseases such as immune diseases, cancer, aging-related diseases, etc. โ€ฆSee details»

Pin Therapeutics - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โ€ฆSee details»

Pin Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials

Mar 5, 2025 www.pintherapeutics.com. Startups | Holding Company | 2017 | Gyeonggi-do, South Korea | 10-50 | www.pintherapeutics.com. Last update 05 Mar 2025. Overview. Pipeline. Deal. โ€ฆSee details»

Pin Therapeutics - Products, Competitors, Financials, โ€ฆ

Pin Therapeutics implements CDD Vault to facilitate collaborative research in Targeted Protein Degradation. Jan 31, 2023. News Provided By Share This Article CDD Vault research informatics system SEOUL, SOUTH KOREA, โ€ฆSee details»

Pin Therapeutics - BIO International Convention 2025

Pin Therapeutics was founded in South Korea in 2018. We are an innovative biotech company developing a targeted protein degradation platform focused on novel E3 ligases (PinE3) and โ€ฆSee details»

Pin Therapeutics, Inc. Overview | SignalHire Company Profile

Pin Therapeutics, Inc. headquarters is in Seongnam-si, Gyeonggi-do. Pin Therapeutics, Inc. is in the sectors of: Biotech. To connect with Pin Therapeutics, Inc.'s employee register on SignalhireSee details»

Pin Therapeutics, Inc. (United States) - Drug pipelines, Patents ...

Explore Pin Therapeutics, Inc. (United States) with its drug pipeline, therapeutic area, technology platform, .See details»

Invest In Pin Therapeutics Stock | Buy Pre-IPO Shares | EquityZen

Apr 13, 2024 Pin Therapeutics is founded in Feb 2017, fast growing stage with member composition of 25% in USA and 75% in Korea. Drug discovery leaderships are from global โ€ฆSee details»

Pin Therapeutics - VentureRadar

Pin Therapeutics, Inc. is a biotech company developing protein degradation therapeutics applicable to various diseases such as immune diseases,... ... Find out more ...See details»

Pin Therapeutics Stock Price, Funding, Valuation, Revenue

Dec 24, 2024 pintherapeutics.com. Overview & Products; Financials; People; Alternatives & Competitors; Customers; Total Raised $35.52M. Investors Count 20. Funding, Valuation & โ€ฆSee details»

Pin Therapeutics to Speak at ACCESS CHINA Partnering Forum

September 16th, 2024 (Shanghai) โ€” We are glad to announce that Armin Dadafshar, the Global Business Development Manager of Pin Therapeutics, will be presenting at the ACCESS โ€ฆSee details»

Pin Therapeutics - Overview, News & Similar companies - ZoomInfo

Jan 30, 2023 Pin Therapeutics implements CDD Vault to facilitate collaborative research in Targeted Protein Degradation SEOUL, SOUTH KOREA, January 31, 2023 โ€ฆSee details»

Pin Therapeutics implements CDD Vault to facilitate collaborative ...

Jan 30, 2023 Pin Therapeutics (www.pintherapeutics.com, "Pin") is a biotech company in Targeted Protein Degradation (TPD) field and located in South Korea and SF. With the experts โ€ฆSee details»

PIN A1 - AdisInsight

If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโ€™s network Login with username/password or try to โ€ฆSee details»

linkstock.net © 2022. All rights reserved